Skip to main content
Caplight Logo









Every Body Eat®

Every Body Eat®

Private
Evanston, IllinoisConsumer & Commercehttps://everybodyeating.com/

Last Round

Grant

Sep 10, 2023

Total Funding Raised

$1.07M

Company Overview

Every Body Eat® is a food and beverage company that produces plant-based, allergen-free snacks intended for people with and without dietary restrictions.

Sector

Consumer & Commerce

Verticals

D2C Brands, Home & Lifestyle, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

allergen-free snacksplant-based snacksfree-from foodCPGconsumer packaged goodsgluten-free snacksspecialty foodDTCdirect-to-consumerhealthy snacksclean label fooddietary restrictionsfood allergy safeinclusive snacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Every Body Eat® Comparables

Compare Every Body Eat® with similar companies based on industry and business-model similarity.

Every Body Eat® comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The Safe + Fair Food Company
89%
Partake Foods
88%
Blake's Seed Based
84%

Every Body Eat® Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 10, 2023
AcceleratorMar 1, 2022
GrantNov 17, 2021
VC RoundMar 19, 2021

Key People

Founding team and executive leadership

Trish Thomas

Co-Founder Chief Eating Officer (CEO)

Founding Team

Bill Kimball

Chief Operating Officer

Executive Team

Every Body Eat® Investors

Notable investors and investment history

Every Body Eat® investors
InvestorRounds
Center for Regional Economic AdvancementGrant
Emerging Brands AllianceGrant
Cleveland AvenueVC Round
Grow NYGrant
SnackFuturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 13, 2025

    Attended the Expo West 2025 event.

  • Feb 13, 2025

    Named a NEXTY Award finalist at Expo West 2025.

Every Body Eat® Filings

Explore SEC and related filing metadata, where available.

Every Body Eat® filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Every Body Eat®'s valuation, stock price, and market status.

Is Every Body Eat® a public or private company?

Every Body Eat® is a private company.

What is the current stock price of Every Body Eat®?

Every Body Eat® is a private company with no public stock price. No recent secondary market data is available.

How much is Every Body Eat® worth (valuation)?

Valuation information for Every Body Eat® is not publicly available.

Can I buy Every Body Eat® stock?

Every Body Eat® shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Every Body Eat®'s last funding round?

Every Body Eat®'s most recent funding round was Grant on September 21, 2023.

Who are the main investors in Every Body Eat®?

Key investors in Every Body Eat® include Emerging Brands Alliance, Cleveland Avenue, Grow NY.

Will Every Body Eat® IPO soon?

No public IPO plans have been announced for Every Body Eat®.

How can I track Every Body Eat® secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Every Body Eat®'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEvanston, Illinois
Employee Range17
Year Founded2018
Last FundingSep 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?